Matches in Wikidata for { <http://www.wikidata.org/entity/Q37838346> ?p ?o ?g. }
- Q37838346 description "article científic" @default.
- Q37838346 description "article scientifique" @default.
- Q37838346 description "articolo scientifico" @default.
- Q37838346 description "artigo científico" @default.
- Q37838346 description "artículu científicu espublizáu en 2011" @default.
- Q37838346 description "bilimsel makale" @default.
- Q37838346 description "scientific article published on July 2011" @default.
- Q37838346 description "vedecký článok" @default.
- Q37838346 description "vetenskaplig artikel" @default.
- Q37838346 description "videnskabelig artikel" @default.
- Q37838346 description "vědecký článek" @default.
- Q37838346 description "wetenschappelijk artikel" @default.
- Q37838346 description "wissenschaftlicher Artikel" @default.
- Q37838346 description "наукова стаття, опублікована в липні 2011" @default.
- Q37838346 description "научни чланак" @default.
- Q37838346 description "مقالة علمية نشرت في يوليو 2011" @default.
- Q37838346 name "Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents" @default.
- Q37838346 name "Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents" @default.
- Q37838346 name "Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents" @default.
- Q37838346 type Item @default.
- Q37838346 label "Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents" @default.
- Q37838346 label "Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents" @default.
- Q37838346 label "Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents" @default.
- Q37838346 prefLabel "Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents" @default.
- Q37838346 prefLabel "Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents" @default.
- Q37838346 prefLabel "Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents" @default.
- Q37838346 P1433 Q37838346-81217305-064F-4E6A-A00D-800E6F8461AB @default.
- Q37838346 P1476 Q37838346-21CC7D9D-C297-4F4B-AAB9-585EF6842DF6 @default.
- Q37838346 P2093 Q37838346-38840EE1-BAFC-477D-85C4-A54D52CC28AC @default.
- Q37838346 P2093 Q37838346-677589DB-8C47-401C-B8D4-41EAFB621F11 @default.
- Q37838346 P2093 Q37838346-A9118774-6BE5-4362-885A-9CC7D409B222 @default.
- Q37838346 P2860 Q37838346-0BE9E4DA-C4E4-4DC8-B08A-246030522F1D @default.
- Q37838346 P2860 Q37838346-114875E2-110D-4F9B-B7A9-4CDA273F4B98 @default.
- Q37838346 P2860 Q37838346-13BF3504-007B-4F76-9012-3E5D6E5BC315 @default.
- Q37838346 P2860 Q37838346-1480572D-2429-4196-B17B-521BDF2A5B45 @default.
- Q37838346 P2860 Q37838346-2074183B-E402-425F-BF09-C488679863B2 @default.
- Q37838346 P2860 Q37838346-31C12F0C-548B-4D58-9A47-059C5042BF05 @default.
- Q37838346 P2860 Q37838346-3A0778BE-987D-47A6-B5F5-0391400A0E26 @default.
- Q37838346 P2860 Q37838346-4DF9FC88-E866-4279-B926-0B60DA58EC9D @default.
- Q37838346 P2860 Q37838346-60B24DD6-65BE-4226-9CE1-B0BA38FB3386 @default.
- Q37838346 P2860 Q37838346-61024702-2A79-48E6-931E-435BAF155D84 @default.
- Q37838346 P2860 Q37838346-787EB2BB-4BB0-4D39-8282-DF447544B638 @default.
- Q37838346 P2860 Q37838346-803B6DBA-747D-4E2D-A08E-6B36C67D7CCA @default.
- Q37838346 P2860 Q37838346-91FFE73E-B216-4454-AE2A-DEBCBBC48012 @default.
- Q37838346 P2860 Q37838346-A88A7BBA-75F3-43BD-880C-BEB497E02AEF @default.
- Q37838346 P2860 Q37838346-C6C5A926-926B-4A68-9320-7690629CEB12 @default.
- Q37838346 P2860 Q37838346-CC0D6634-18A8-40B4-894C-18891907E9E1 @default.
- Q37838346 P2860 Q37838346-DDE834E7-9BDA-46E4-8883-8B0F4E505F1C @default.
- Q37838346 P2860 Q37838346-E85E48B5-BBEE-47F1-9D53-401F07F879EA @default.
- Q37838346 P2860 Q37838346-F86CDFCF-6EE2-4BE2-A1F0-C684FC9F16CA @default.
- Q37838346 P2860 Q37838346-F9CB7893-8844-4078-B6F5-148CB12D1078 @default.
- Q37838346 P2860 Q37838346-FA1800A2-6FD6-4DD5-B53E-C6C26BF0EF0C @default.
- Q37838346 P2860 Q37838346-FB2715F4-553C-493F-9A01-CB19EAD96E23 @default.
- Q37838346 P304 Q37838346-09527A4F-37B6-4391-BDA7-33C4833BA21A @default.
- Q37838346 P31 Q37838346-2EAA23BD-5ED6-44F9-A71A-10C814C6FC03 @default.
- Q37838346 P356 Q37838346-189CEB8E-A4CC-42B1-9CFA-88D4B063F8D6 @default.
- Q37838346 P433 Q37838346-4B78319D-CCF6-43DA-96DF-F6B65E8A8F14 @default.
- Q37838346 P478 Q37838346-FE0D520F-809A-4823-B835-A124039E87CB @default.
- Q37838346 P50 Q37838346-14549B5B-AF70-407C-8E15-2E33F09D571D @default.
- Q37838346 P50 Q37838346-48C69D9B-C428-41A1-B49F-F386F91A683C @default.
- Q37838346 P577 Q37838346-4E5902F0-210D-4137-907F-B6002C12F44F @default.
- Q37838346 P5875 Q37838346-04F99838-4B3C-4023-9D06-467AA806BCE4 @default.
- Q37838346 P698 Q37838346-54353363-614C-4120-AB9C-2284E13A6390 @default.
- Q37838346 P921 Q37838346-3D23DE97-97EA-4656-8350-FC165BC901B2 @default.
- Q37838346 P356 ART.30247 @default.
- Q37838346 P698 21305513 @default.
- Q37838346 P1433 Q4797636 @default.
- Q37838346 P1476 "Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents" @default.
- Q37838346 P2093 "Anti-Rheumatic Therapy in Sweden Study Group" @default.
- Q37838346 P2093 "Johan Askling" @default.
- Q37838346 P2093 "Pauline Raaschou" @default.
- Q37838346 P2860 Q27860872 @default.
- Q37838346 P2860 Q31122446 @default.
- Q37838346 P2860 Q33186052 @default.
- Q37838346 P2860 Q33236702 @default.
- Q37838346 P2860 Q33243658 @default.
- Q37838346 P2860 Q33385593 @default.
- Q37838346 P2860 Q33749195 @default.
- Q37838346 P2860 Q34498486 @default.
- Q37838346 P2860 Q35551908 @default.
- Q37838346 P2860 Q35554823 @default.
- Q37838346 P2860 Q35554865 @default.
- Q37838346 P2860 Q35637262 @default.
- Q37838346 P2860 Q35954490 @default.
- Q37838346 P2860 Q36585132 @default.
- Q37838346 P2860 Q37259363 @default.
- Q37838346 P2860 Q37328554 @default.
- Q37838346 P2860 Q37502929 @default.
- Q37838346 P2860 Q39962493 @default.
- Q37838346 P2860 Q43796083 @default.
- Q37838346 P2860 Q44499208 @default.
- Q37838346 P2860 Q44536841 @default.
- Q37838346 P2860 Q44968566 @default.
- Q37838346 P304 "1812-1822" @default.
- Q37838346 P31 Q13442814 @default.
- Q37838346 P356 "10.1002/ART.30247" @default.
- Q37838346 P433 "7" @default.
- Q37838346 P478 "63" @default.
- Q37838346 P50 Q42647701 @default.
- Q37838346 P50 Q47272088 @default.